Tomorrow Bio is a Biotech firm that specializes in human cryopreservation. They use cutting-edge technology to keep you alive in the future.
Tomorrow Bio has raised $5.6M in total funding. The most recent round was Seed. The last funding was announced in May 2025.
Tomorrow Bio's investors include Blast. Club, TruVenturo.
Tomorrow Bio is headquartered in Berlin, Germany.
Tomorrow Bio is a Biotech firm that specializes in human cryopreservation. They use cutting-edge technology to keep you alive in the future.
Tomorrow Bio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Tomorrow Bio — Funding & Investors." VCBacked, May 22, 2025, https://www.vcbacked.co/company/tomorrow-bio. Accessed September 2, 2026.
VCBacked. (2025). Tomorrow Bio — Funding & Investors. Retrieved September 2, 2026, from https://www.vcbacked.co/company/tomorrow-bio
{{cite web |title=Tomorrow Bio — Funding & Investors |url=https://www.vcbacked.co/company/tomorrow-bio |website=VCBacked |access-date=September 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated